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Abstract
In this report, we demonstrate the feasibility of using optoacoustic tomography (OAT) to evaluate
biodistributions of nanoparticles in animal models. The redistribution of single-walled carbon
nanotubes (SWCNTs) was visualized in living mice. Nanoparticle concentrations in harvested
organs were measured spectroscopically using the intrinsic optical absorption and fluorescence of
SWCNTs. Observed increases in optoacoustic signal brightness in tissues were compared with
increases in optical absorption coefficients caused by SWCNT accumulation. The methodology
presented in this report can further be extended to calibrate the sensitivity of an optoacoustic
imaging system for a range of changes in optical absorption coefficient values at specific locations
or organs in a mouse body to enable noninvasive measurements of nanoparticle concentrations in
vivo. Additionally, qualitative information provided by OAT and quantitative information
obtained ex vivo may provide valuable feedback for advancing methods of quantitative analysis
with OAT.
Observed changes in organ brightness in an optoacoustic mouse image can be correlated to
quantitative changes in organ absorption coefficients.
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1. Introduction
In recent years, biomedical applications of nanotechnology have emerged at an increasing
pace. With their minute dimensions and large surface areas, nanoparticles can often
penetrate cellular membranes and deliver high payloads of targeting agents and drugs to
achieve better specificity and therapeutic effects than non-targeted treatments [1,2]. To aid
the development of novel nanotechnology-based therapies, preclinical imaging techniques
are needed to efficiently monitor nanoparticle accumulation and clearance rates in vivo.
However, tedious ex vivo analysis of nanoparticle concentrations in organs of test animals
remains a standard approach in such biodistribution studies [3–6].
While imaging methods, such as single photon emission computed tomography (SPECT),
positron emission tomography (PET), magnetic resonance imaging (MRI) or computer
tomography (CT), are currently available to detect specific types of nanoparticles, they rely
on particular contrast agents and remain inaccessible to most researchers due to high
instrumentation and operational costs [7]. In vivo fluorescence imaging is perhaps the
simplest and most readily available method to observe fluorescent nanoparticles in small
animals. However, it provides limited resolution and imaging depth, and is hampered by
strong scattering of light in tissues.
Optoacoustic tomography (OAT) is an emerging imaging technology that utilizes ultrasound
generated by absorption of nanosecond-scale laser pulses to recreate an image of the
absorbing volume based on the spatial variation of optical absorption coefficients [8, 9].
This novel non-invasive imaging modality is capable of revealing internal organs and
vasculature in three dimensions at depths of several centimeters and resolutions of 500 µm
or less [10]. Three-dimensional OAT was successfully used to visualize the blood
circulation system and blood-rich organs in live mice [11]. Strongly absorbing gold and
carbon nanoparticles were used previously as optoacoustic (OA) contrast agents to enhance
the imaging and detection capabilities of the technique [12–14]. Due to the unknown light
distribution in a complex optical scattering environment, tomographic images of live
animals typically contain only qualitative information and are not suitable for quantitative
biodistribution analysis. In this report, we present a novel methodology that can establish the
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link between localized changes in OAT image intensities in tissues and organs of small
animals and the underlying changes in tissue/organ absorption coefficients caused by
nanoparticle accumulation. This technique represents an important enabling step towards
quantitative in vivo measurements of optically absorbing contrast agents in small animals.
2. Experimental
2.1 Optoacoustic imaging setup
In these studies we used a prototype of a commercial three-dimensional laser optoacoustic
imaging system (LOIS-3D), shown in Figure 1, which was developed for preclinical
research at TomoWave Laboratories, Houston, TX, and introduced in our earlier
publications [10, 14]. Laser pulses at 1064 nm (duration of 12 ns, ~200 mJ/pulse, 10 Hz
repetition rate) were generated by a Nd:YAG component of SpectraWave laser (joint
product of TomoWave Labs, Houston, TX and Quanta Systems, Solbiate Olona, Italy).
Laser light was delivered to the sample via a custom bifurcated fiber bundle, whose outputs
were placed outside of a water tank orthogonally to the transducer array. The laser fluence
measured at the animal’s skin was ~0.8 mJ/(pulse.cm2). The water temperature was
maintained at 36 °C. To acquire OA signals, we used a 64-channel arc array of
piezocomposite elements (Imasonic SAS, France) with a detection bandwidth of 0.1– 3.1
MHz. The array was oriented vertically inside the tank, with an arc radius of 65 mm and an
aperture of 150°. Acquired signals were amplified at a gain of 60 dB and digitized at a 25
MHz sampling rate. During the scan, the mouse was rotated about a vertical axis passing
through the focal center of the array by a total of 360° in 2.4° steps. Signals were averaged
64 times at each step to reach optimal signal to noise ratio. The OA signals acquired at each
rotational position of the mouse were amplified, digitized and saved in a computer. Post-
processing of OA signals included: (1) synchronization with the time of laser emission; (2)
Wiener deconvolution of the system’s acousto-electric impulse response with a constant
signal-to-noise ratio of 10; (3) filtering and integration with the seven scales of the custom-
designed wavelet filter; (4) removal of the first principal component from data of each
individual channel [15]. The principal component analysis was done on a signal basis across
all acquisitions to remove common features found in each particular channel [16]. Three-
dimensional OA tomographic reconstruction was performed using a modified back
projection algorithm [10] with 0.1 mm3 voxels. The OAT software was developed to run on
CUDA-supported graphics processing units of Fermi videocard (NVIDIA, Santa Clara, CA),
resulting in fast reconstruction of three-dimensional OA images (~90 seconds for 50 million
voxels). Image processing and representation in VolView 2.0 (Kitware, Clifton Park, NY)
included: 1) denoising by setting a ramp-like transparency mapping and median filtering
with a 3×3×3 voxel kernel; 2) applying strong edge detection to emphasize large intensity
changes (boundaries); 3) using a linear grayscale palette with saturation at a fixed level
within the dynamic range of all the images.
2.2 Sample preparation and characterization
Suspensions of commercially available single-walled carbon nanotubes (SWCNTs) ((6,5)-
abundant sample from SouthWest NanoTechnologies, Inc.) were prepared as follows.
Approximately 5 mg of SWCNT material was placed in 12 mL of a 2% aqueous solution of
Tsyboulski et al. Page 3
J Biophotonics. Author manuscript; available in PMC 2014 September 03.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
Pluronic F-127 and sonicated with a tip ultrasonic cell processor (Misonics model Microson
2000 XL) for 40 min using on/off cycles with duration of 15 s each. An external water bath
was used to prevent sample heating. The resulting suspension was centrifuged at 10,000 × g
for 15 min to remove large undispersed aggregates. Only a small amount of precipitate
remained after supernatant removal. Absorption and fluorescence (642 nm excitation
wavelength) spectra of the stock SWCNT suspension were measured with a model NS2
NanoSpectralyzer (Applied NanoFluorescence, LLC) (Figure 2A, B).
The optical absorption coefficient µa at 1064 nm was 38 cm−1. Using the experimentally
determined base 10 mass extinction coefficient value of 0.036 mL/ (µg cm) at ~630 nm for
SWCNTs in surfactant suspensions, we estimate the stock SWCNT solution concentration
as ~0.43 mg/mL. Similar extinction coefficient values for SWCNTs were reported
previously [4,17]. We note that Pluronic is a biocompatible surfactant that has been used
earlier for intravenous nanoparticle injections in mammals [6,18].
2.3 Animal handling procedures
All procedures complied with a protocol approved by Institutional Animal Care and Use
Committee (IACUC) of the Univ. of Houston. We used four athymic Nude-Foxn1nu mice
(Harlan, Indianapolis, IN), 7–8 weeks old, weighing about 23–25 g. Animal handling,
isoflurane anesthesia, and euthanasia were described earlier [10,14]. Each mouse was
scanned prior to injection to obtain reference OA images. After the initial scan, 3 mice were
intraperitoneally injected with 400 µL of SWCNT stock solution. A control mouse was
administered 400 µL of a 2% aqueous Pluronic solution. Mice were scanned again 3 days
after injection, and then sacrificed using the method of CO2 inhalation. Their organs were
harvested for further inspection.
2.4 SWCNT concentration measurements in organs of mice
Fluorescence of disaggregated SWCNTs allows one to measure concentrations of SWCNTs
in organs. Organs were rinsed in phosphate buffered saline, and their weights were recorded.
These specimens were then homogenized using a tissue grinder (Ten-broeck, USA) with
added homogenization buffer (2% solution of sodium deoxycholate (SDOC) in H2O) to
provide dilutions of 1 : 15, 1 : 15 and 1 : 40 for liver, kidney and spleen, respectively. A 1.5
mL portion of the homogenized sample was placed in a 2 mL centrifuge tube and sonicated
at an output power of ~8W for 40 min using 10 s on and 5 s off cycles while an external ice
bath prevented sample heating. The required duration of ultrasonic treatment was
determined empirically by repeated measurements of sample’s near-IR fluorescence signal
until no further intensity increase was observed. The resulting suspensions showed very little
scattering, which was beneficial for optical measurements. To prepare a reference sample,
100 µL of the stock SWCNT solution in Pluronic was added to 2 mL of 2% aqueous SDOC
and sonicated as described above to maximize its fluorescence.
Tissue samples without nanotubes typically exhibit structureless autofluorescence and
background absorptions that are markedly different from SWCNT features. Examples of the
recorded emission and absorption spectra of processed organ samples are shown in Figure
3A, B. SWCNT fluorescence and SWCNT absorption peaks at 997 nm were separately used
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to measure nanotube concentrations in these samples. The net peak amplitude Δ (Figure 3A)
is a stable feature of the nanotube absorption which does not change significantly during
sample processing (Supporting Information, Section 1). Thus, comparing Δ values of a
sample and a reference solution containing a known nanotube concentration allows one to
measure SWCNT concentration in the sample.
The fluorescence method provides much higher sensitivity for measuring SWCNTs in
biological specimens. Note that biological residues present in samples may interact with
nanotubes to perturb their emission wavelengths and/or emission intensities. To account for
these effects, we used the following procedure. The sample’s emission spectrum was
measured, and then a 1.5 mL portion was spiked with precisely 10 or 20 µL of the reference
SWCNT suspension in SDOC. The resulting mixture was briefly sonicated for 1 min to
facilitate equilibration of surfactant and biological residues at the surface of added
nanotubes. Then we measured the emission spectrum of the resulting suspension and
determined the increase in distinct SWCNT features caused by spiking. This allowed us to
reliably deduce the initial SWCNT concentration in the specimen (see Supporting
Information, Section 1 for details).
3. Results and discussion
The brightness of a particular organ or tissue in an OAT image is defined by the amount of
light it absorbs, and thus depends on the organ’s optical absorption coefficient µa and the
amount of light that reaches it. A localized increase in OA image brightness generally
implies an increase in µa value at that location. OA will detect nanoparticle accumulation as
well as changes in blood or water saturation levels in organs. Figure 4 shows dorsoventral
(back), left medio-lateral, and right medio-lateral OA images of a mouse before and after
SWCNT injection. Significant increases in brightness are seen at the locations of liver and
spleen, as well as the mouse skeleton. However, mouse kidneys show no noticeable
brightness increases. Note that it is not feasible to overlay these images to show only
localized changes in brightness because the precise mouse positioning differs between scans.
Prior mammalian pharmacokinetic studies of carbon nanotubes suspended in Pluronic and
other surfactants found predominant nanotube accumulation in liver and spleen after
intravenous injection [6,18,19]. Our OAT images show qualitatively similar information.
To quantify OA brightness of selected organs, namely liver, kidney and spleen, we selected
a 2×2×2 mm region of interest (ROI), which fit inside the organ at approximately similar
locations, and calculated the average voxel intensity values. The measured OA signals from
organs of 4 mice are presented in Figure 5. We analyzed OA signals from organs of a few
selected mice by shifting the ROI position within visible boundaries of a particular organ
and evaluating variations in the corresponding average intensity values. We estimate that the
error in the measured OA signal values associated with arbitrary positioning of the ROI
inside an organ is ~15–20%. (We are currently developing numerical image processing
algorithms that should provide better accuracy in quantifying optoacoustic response from an
organ.) We observed no significant changes in the OA signal magnitudes from the organs of
the control mouse before and after Pluronic injection. On average, OA signals from spleen
and liver increased by 60% and 360%, respectively from SWCNT injection (Figure 5).
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These changes can be attributed predominantly to the accumulation of nanoparticles in these
organs. Note that while it is not possible to entirely disregard physiological responses to
injection of nanoparticles in an organism, their contributions at the imaging wavelength of
1064 nm are expected to be negligible. No abnormalities such as liver or spleen
haemorrhages were detected in these mice during post mortem examination.
Quantitative measurement of µa in tissues using OAT is a complex problem that requires
knowledge of the light distribution throughout the sample [11, 20, 21]. Although methods to
quantify light intensities in tissues are being developed [20–22], their application in live
animal models is not feasible at present. Indeed, the strong dependence of light penetration
depth on µa in different organs and tissues, which is not known a priori; imprecisely known
scattering properties of tissues; and complex and poorly characterized scattering
environment geometries pose overwhelming difficulties for rigorous analysis and modeling
of light distributions in live animals. Here we suggest an alternative and simplified method
to enable concentration measurements of nanoparticles in vivo. By establishing a
quantitative correlation between the changes in OA signal brightness from a specific organ
and the corresponding changes in organ’s µa value in a given experimental geometry,
concentration measurements of optical absorbers in vivo may become feasible.
The proposed approach represents a method for calibrating sensitivity of an optoacoustic
imaging system in a particular experimental geometry and for specific type of animal. The
differences in the amount of energy absorbed in a selected organ caused by natural
variability of tissue optical properties from animal to animal are expected to be the major
source of error in concentration measurements. The influence of acoustic attenuation on the
accuracy of the method will be smaller, given significantly weaker attenuation and scattering
of ultrasound waves in tissues. Athymic nude mice used in this work represent one of the
standard cancer models. They are genetically uniform with very similar characteristics,
which means that optical properties of their tissues and organs are similar. As a result,
variability of light distribution in organs of different animals may not be excessive, and the
suggested methodology will allow quantitative measurements, albeit with a limited
accuracy. To our best knowledge, there have been no prior attempts to perform rigorous
quantitative analysis of three-dimensional OAT images of small animals which include the
modeling of light distributions throughout the imaging volume [21]. The presented
methodology may further be applied to help develop and test future quantitative analytical
techniques.
Brightness of an organ or an area in a reconstructed OA image is a complex function of
many parameters, including the light distribution at this location, optical absorption contrast
relative to its surroundings, the frequency spectrum of generated signals, and the detection
bandwidth of the acoustic probe. Acoustic artifacts, as well as signal processing and image
reconstruction algorithms, may change the background level at a specific location by an
unknown value. It is expected that small increases in an organ’s µa will initially result in
linear changes in OA signal magnitudes. However, large µa increases will affect the
distribution of light in an organ and its surroundings, which would result in a nonlinear
response. In an extreme case when all light reaching the organ is absorbed at its surface,
further µa increase will not produce any additional increase in OA image brightness. Thus,
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one may expect an organ’s OAT brightness to show a monotonic and sublinear dependence
on its µa value.
For a number of reasons, SWCNTs appear to be highly suitable contrast agents for
quantifying changes in organ optical absorption. First, the bulk absorption spectrum of
SWCNTs is fairly stable and not particularly sensitive to nanotube aggregation or changes to
the SWCNT coating [18, 23, 24] (Supporting Information, Section 2). Second, SWCNTs in
a biological environment can be detected by a variety of sensitive techniques, including
fluorescence [6, 18], Raman [3, 19] and absorption spectroscopy, to obtain a reliable
measure of SWCNT concentrations in mouse organs. Third, SWCNTs are physically and
chemically stable and, unlike most dyes, cannot be easily photobleached by laser pulses [25,
26] or metabolized in vivo [27]. Note that even a small degree of SWCNT surface
derivatization or structural damage results in strong quenching of SWCNT fluorescence but
little change in SWCNT absorption [28].
SWCNT concentrations in organs of mice, measured with absorption and fluorescence
spectroscopy as described in the experimental section, are shown in Figure 6A. Absorption
features attributable to SWCNTs were reliably detected only in the liver and spleen samples.
Notably, the fluorescence method appears to consistently underestimate SWCNT
concentrations by ~22% on average. While the origin of the observed discrepancy remains
to be clarified, possible sources of error include potential SWCNT functionalization while in
vivo, or the partial quenching of SWCNT fluorescence by biological residues present in the
processed organ samples (see Supporting Information, Section 1 for details). Organ weights
in all three mice were similar: liver − 1.5 ± 0.1 g, spleen − 0.105 ± 0.004 g, kidney − 0.21 ±
0.02 g. Averaged SWNCT concentrations in the liver, spleen, and kidneys of 3 mice were 43
± 8, 47 ± 8 and 2.4 ± 0.8 µg/g, respectively. We estimate that approximately 65 µg of
SWCNT material (~38% of the injected dose) was accumulated in these organs 3 days after
SWCNT injection. Assuming a uniform distribution of nanoparticles in an organ, the µa of
liver and spleen at 1064 nm was increased by ~3.8 cm−1 and ~4.7 cm−1, respectively. Since
the initial µa values of mouse organs are unknown, we can present only a preliminary
calibration graph showing the connection between measured OA signals from organs and
the corresponding µa values. For comparison, reported µa values of liver (human, bovine)
and spleen (human, albino rat) at 1064 nm are ~0.4– 0.7 cm−1, and ~6 cm−1, respectively
[29–31].
Figure 6B demonstrates the observed correlation between SWCNT concentration in organs
and the corresponding change in brightness in OAT image. There appears to be qualitative
agreement between the changes in OA signal magnitude and organ µa relative to the initial
values. The absence of a clear monotonic dependence of OA signals on SWCNT
concentration in organs suggests the presence of additional sources of error in the imaging
method (e.g. variation in optical properties of tissues from animal to animal, differences in
their organ sizes and positioning geometry). Additional studies involving larger animal
subgroups with different concentrations of nanoparticles in their organs will be needed to
reveal this trend and define the magnitude of the measurement error.
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4. Conclusion
Quantitative in vivo measurements of nanoparticle concentrations are essential for
nanotechnology-based preclinical research. We have developed a methodology to correlate
changes in optoacoustic signal intensity from organs of live animals detected with OAT in
relation to changes of optical absorption coefficient in those organs. The localized OAT
brightness changes induced by nanoparticle accumulation in liver, kidney and spleen of nude
mice were observed and quantified. Using the intrinsic fluorescence properties of
disaggregated nanotubes, we readily measured SWCNT concentrations in the parts-per-
million range in these organs and defined the corresponding changes in optical absorption
coefficient. The combination of these methods allows one to perform sensitivity calibration
of an OAT system for a selected type of animal and for a range of optical absorption
coefficient values of their organs to enable non-invasive concentration measurements of
optically absorbing nanoparticles and dyes in vivo. Furthermore, the methodology presented
here may aid in the development and testing of new methods of optoacoustic quantitative
analysis.
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Figure 1.
(A) A photograph of the LOIS-3D system. (B) A photograph of a mouse in a water tank
during the scan. (C) A sketch of the experimental geometry showing the relative position of
the illumination and detection elements.
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Figure 2.
(A) Absorption and (B) emission (λexc = 642 nm) spectra of a stock SWCNT Pluronic
suspension.
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Figure 3.
(A) Absorption and (B) emission spectra (λexc = 642 nm) of liver, spleen, and kidney
samples. Spectra of a reference solution with nanotube concentration of ~4.3 µg/mL are
shown for comparison.
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Figure 4.
OA images of a mouse before and 3 days after SWCNT injection. The grayscale intensity is
the same for all images. Dorsoventral, left medio-lateral, and right medio-lateral views are
shown. S, L, K show locations of spleen, liver and kidney, respectively.
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Figure 5.
Averaged OA signals from organs of 4 mice measured before and 3 days after SWCNT
injection.
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Figure 6.
(A) Concentrations of SWCNTs in organs of mice measured 3 days after injection. (B)
Correlation of OA signals from organs of 4 mice with the measured concentrations of
SWCNTs accumulated in these organs. Vertical error bars show the estimated measurement
error of OA organ brightness. Horizontal error bars show the discrepancy between
concentration measurements via SWCNT absorption and fluorescence.
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